Condition
White Matter Hyperintensity
Total Trials
6
Recruiting
1
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Terminated1
Unknown1
Active Not Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04532697Not ApplicableCompleted
Use of Gou-Teng to Treat Patients With Mild Cognitive Impairment
NCT06533631CompletedPrimary
Measuring Brain Health Using Low-Field Portable MRI
NCT05586750Phase 4Active Not Recruiting
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
NCT06715007Recruiting
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
NCT04465448TerminatedPrimary
Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)
NCT05982470Phase 2Unknown
Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI
Showing all 6 trials